期刊文献+

重组人生长激素对大鼠随意皮瓣成活的影响 被引量:6

Effect of recombinant human growth hormone on survival of free skin flaps in rats
下载PDF
导出
摘要 目的探讨重组人生长激素(rhGH)对大鼠随意皮瓣成活的影响。方法将24只健康的Wistar大鼠随机分为两组,每组12只。在其背部制作随意皮瓣后,分别在皮瓣的皮下注射0.25ml(0.1IU/kg)的rhGH(实验组)和0.25ml的生理盐水(对照组),观察两组皮瓣的成活面积及成活率,并行免疫组化检查。结果实验组的皮瓣成活率及皮瓣的中段、远段的血管密度和VEGF的表达均较对照组高,实验组皮瓣血管的再生明显多于对照组。结论rhGH能直接或间接地促进皮瓣血管的生成,提高随意皮瓣成活的面积。 Objective To study the function of recombinant human growth hormone (rhGH) on the survival of the free skin flaps in rats. Methods Twenty - four Wistar rats were randomly divided into two groups with 12 rats in each group, anda free dorsal skin flap was established in each animal. In the experimental group each rat was given a subcutaneous injection with rhGH (0.1 IU/kg, total volume 0.25 ml) under the skin flap and the control group animals each received a saline injection under the flap of the same volume. The viable area and survival rate of all flaps were observed, and an immonohistochemical test was performed. Results The flap survival rate in the experimental group was remarkably higher than that in the control group. The blood vessels density in the middle and distal segments of the flap was greater and the expression of VEGF in the experimental group was stronger than that in the control group. Histological semiquanfi tative analysis showed neovascularizations in flaps treated with rhGH was much greater than that in the control group. Conclusion rhGH can direly or indirectly promote vascularization and increase both the flap survival rate and area viability of the free skin flaps.
出处 《中国美容整形外科杂志》 CAS 2007年第2期87-90,共4页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 重组人生长激素 随意皮瓣 皮下注射 血管密度 VEGF Recombinant human growth hormone (rhGH) Free skin flap Subcutaneous injection Blood vessel density VEGF
  • 相关文献

参考文献10

二级参考文献80

  • 1顾军,黎介寿,李维勤,黄进,尹路,刘放南.重组生长激素对严重感染后蛋白质代谢影响的实验研究[J].中华外科杂志,1997,35(2):104-107. 被引量:127
  • 2王正国.创伤后组织修复研究的现状与展望[J].中华创伤杂志,1995,11(3):131-131.
  • 3孙国柱 符小兵 孙晓庆 等.重组人酸性成纤维生长因子促进皮肤缺损创面愈合的量效关系[J].现代康复,2001,5(9):31-31.
  • 4[1]Ian Zachary.Molecules in focus vascular endothelial growth factor.The International Journal of Biochemistry & Cell Biology,1998,30:1169-1174.
  • 5[2]Maxwell PH.Activation of the HIF pathway in cancer.Curr Opin Genet Dev,2001,11:293-299.
  • 6[3]Christitane BH,Edurne B,Jacques P.Hypoxia:the tumor's gateway to progression along the angiogenic pathway.Trends in Cell Biology,2001,11:32-36.
  • 7[4]Teraoka H,Nishihara T,Ohira M,et al.Enhanced VEGF production decreased immunogenicity induced by TGF-β1 promote liver metastasis of pancreatic cancer.Br J Cancer,2001,85:612-617.
  • 8[5]Ravi R,Mookergee B,Bhujwalla Z,et al.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α.Genes Dev,2000,14:34-44.
  • 9[6]Soumitro P,Kaustubh D,Dababrata M.Central role of P53 on regulation of vascular permeability factor/vascular endothelial factor(VPF/VEGF)expression in mammary crcinoma.Cancer Research,2001,61:6952-6956.
  • 10[7]Ikeda N,Adachi M,Taki T,et al.Prognostic significance of angiogenesis in human pancreatic cancer.Br J Cancer.1999,79:1553-1563.

共引文献35

同被引文献72

引证文献6

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部